SG Americas Securities’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
CC
SG Americas Securities's PRCT Position: Q2 2026 in Review
SG Americas Securities reduced its Procept Biorobotics (PRCT) stake by 51% in Q2 2026, selling an estimated $429K and leaving 16,569 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.
SG Americas Securities first reported a position in PRCT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.65M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.
- SG Americas Securities held 16,569 shares of Procept Biorobotics worth $374K as of Q2 2026.
- SG Americas Securities sold 17,147 Procept Biorobotics shares in Q2 2026, an estimated $429K.
- Procept Biorobotics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2475 holding.
- SG Americas Securities first reported a position in Procept Biorobotics in Q4 2022 and has held it in 14 quarters since.
- SG Americas Securities's Procept Biorobotics position peaked at $2.65M in Q4 2025.
- 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.